Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
2003 1
2006 2
2009 1
2010 2
2011 8
2012 5
2013 7
2014 5
2015 7
2016 19
2017 18
2018 18
2019 18
2020 12
2021 9
2022 3
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. Among authors: zeitz j. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
[Meulengracht disease].
Zeitz J, Schmidinger I, Rentsch K, Rogler G, Vavricka S. Zeitz J, et al. Praxis (Bern 1994). 2013 Jan 30;102(3):129-35. doi: 10.1024/1661-8157/a001212. Praxis (Bern 1994). 2013. PMID: 23384981 Free article. German. No abstract available.
Follow-Up of Celiac Disease in Adults: "When, What, Who, and Where".
Mulder CJJ, Elli L, Lebwohl B, Makharia GK, Rostami K, Rubio-Tapia A, Schumann M, Tye-Din J, Zeitz J, Al-Toma A. Mulder CJJ, et al. Among authors: zeitz j. Nutrients. 2023 Apr 24;15(9):2048. doi: 10.3390/nu15092048. Nutrients. 2023. PMID: 37432208 Free PMC article. Review.
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.
Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, Sarin J, Huhtala H, Hiltunen P, Zimmermann T, Mohrbacher R, Greinwald R, Lundin KEA, Schuppan D, Mäki M, Viiri K; CEC-3 Investigators. Dotsenko V, et al. Nat Immunol. 2024 Jul;25(7):1218-1230. doi: 10.1038/s41590-024-01867-0. Epub 2024 Jun 24. Nat Immunol. 2024. PMID: 38914866 Free PMC article. Clinical Trial.
Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations.
Juillerat P, Manz M, Sauter B, Zeitz J, Vavricka SR; Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Juillerat P, et al. Among authors: zeitz j. Digestion. 2020;101 Suppl 1:83-97. doi: 10.1159/000502816. Epub 2020 Feb 17. Digestion. 2020. PMID: 32066137 Free article. Review.
Microbial network disturbances in relapsing refractory Crohn's disease.
Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators; Wiest R, Stelling J, Macpherson AJ. Yilmaz B, et al. Nat Med. 2019 Feb;25(2):323-336. doi: 10.1038/s41591-018-0308-z. Epub 2019 Jan 21. Nat Med. 2019. PMID: 30664783
[BCG-vaccination and tuberculosis].
Simon K, Zeitz J. Simon K, et al. Among authors: zeitz j. Dtsch Med Wochenschr. 1973 May 4;98(18):942-5. doi: 10.1055/s-0028-1106938. Dtsch Med Wochenschr. 1973. PMID: 4700740 German. No abstract available.
Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
Jordi SBU, Lang BM, Auschra B, von Känel R, Biedermann L, Greuter T, Schreiner P, Rogler G, Krupka N, Sulz MC, Misselwitz B, Begré S; Swiss IBD Cohort Study Group. Jordi SBU, et al. Inflamm Bowel Dis. 2022 Mar 30;28(4):560-571. doi: 10.1093/ibd/izab136. Inflamm Bowel Dis. 2022. PMID: 34096587
126 results